Medibio Ltd
ASX:MEB

Watchlist Manager
Medibio Ltd Logo
Medibio Ltd
ASX:MEB
Watchlist
Price: 0.02 AUD Market Closed
Market Cap: 122m AUD
Have any thoughts about
Medibio Ltd?
Write Note

Gross Margin
Medibio Ltd

100%
Current
92%
Average
47.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
100%
=
Gross Profit
963.6k
/
Revenue
963.8k

Gross Margin Across Competitors

Country AU
Market Cap 122m AUD
Gross Margin
100%
Country US
Market Cap 35B USD
Gross Margin
73%
Country US
Market Cap 31.3B USD
Gross Margin
83%
Country AU
Market Cap 23.2B AUD
Gross Margin
100%
Country US
Market Cap 9B USD
Gross Margin
90%
Country JP
Market Cap 967.6B JPY
Gross Margin
58%
Country US
Market Cap 5.7B USD
Gross Margin
85%
Country US
Market Cap 5.4B USD
Gross Margin
67%
Country SE
Market Cap 53.1B SEK
Gross Margin
47%
Country US
Market Cap 2.4B EUR
Gross Margin
66%
Country CN
Market Cap 16.4B CNY
Gross Margin
43%
No Stocks Found

Medibio Ltd
Glance View

Market Cap
122m AUD
Industry
Health Care

Medibio Ltd. engages in the clinical research, product development and early stage commercialization of a mental health technology. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2001-01-29. The firm offers mental well-being solutions for businesses and are also developing products to serve the healthcare provider market. The company offers a software called MEBsleep, a medical device that analyses Electroencephalogram (EEG) and Electrocardiogram (ECG) data collected during polysomnography to verify sleep stages and heart rate variability (HRV) in patients suffering from primary or secondary sleep disturbances. The Company’s subsidiaries include Bioprospect Australia Pty Ltd, Australian Phytochemicals Pty Ltd, BioProspect America Pty Ltd, Medibio Limited USA, Invatec Health Pty Ltd and Annapanna Pty Ltd.

MEB Intrinsic Value
0.001 AUD
Overvaluation 97%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
100%
=
Gross Profit
963.6k
/
Revenue
963.8k
What is the Gross Margin of Medibio Ltd?

Based on Medibio Ltd's most recent financial statements, the company has Gross Margin of 100%.